Literature DB >> 10943690

Differential expression of c-fos following administration of two tremorgenic agents: harmaline and oxotremorine.

H Miwa1, K Nishi, T Fuwa, Y Mizuno.   

Abstract

The regional distribution of c-Fos expression in the brain after the administration of two tremorgenic agents was studied. In both the harmaline- and oxotremorin-treated rats, c-Fos-positive neurons were extensively distributed in the basal ganglia nuclei and the cerebellum. Additionally, in the harmaline-treated rats, numerous c-Fos-positive neurons were also distributed throughout the inferior olivary nucleus. In the oxotremorine-treated rats, while the inferior olive was not involved, c-Fos was strongly expressed in the neurons of the reticular thalamic nucleus, possibly due to the muscarinic effects of oxotremorine. The present study revealed that the inferior olive is selectively activated in the harmaline-administered animals and that the basal ganglia are involved in both harmaline- and oxotremorine-induced tremors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10943690     DOI: 10.1097/00001756-200008030-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

Review 1.  Current Opinions and Consensus for Studying Tremor in Animal Models.

Authors:  Sheng-Han Kuo; Elan D Louis; Phyllis L Faust; Adrian Handforth; Su-Youne Chang; Billur Avlar; Eric J Lang; Ming-Kai Pan; Lauren N Miterko; Amanda M Brown; Roy V Sillitoe; Collin J Anderson; Stefan M Pulst; Martin J Gallagher; Kyle A Lyman; Dane M Chetkovich; Lorraine N Clark; Murni Tio; Eng-King Tan; Rodger J Elble
Journal:  Cerebellum       Date:  2019-12       Impact factor: 3.847

2.  Tremorolytic effect of 5'-chloro-5'-deoxy-(±)-ENBA, a potent and selective adenosine A1 receptor agonist, evaluated in the harmaline-induced model in rats.

Authors:  Barbara Kosmowska; Krystyna Ossowska; Urszula Głowacka; Jadwiga Wardas
Journal:  CNS Neurosci Ther       Date:  2017-03-29       Impact factor: 5.243

3.  Quantitative measurement of postural sway in mouse models of human neurodegenerative disease.

Authors:  D Hutchinson; V Ho; M Dodd; H N Dawson; A C Zumwalt; D Schmitt; C A Colton
Journal:  Neuroscience       Date:  2007-07-21       Impact factor: 3.590

4.  Endocannabinoid signaling in neurotoxicity and neuroprotection.

Authors:  C Pope; R Mechoulam; L Parsons
Journal:  Neurotoxicology       Date:  2009-12-05       Impact factor: 4.294

Review 5.  Linking Essential Tremor to the Cerebellum-Animal Model Evidence.

Authors:  Adrian Handforth
Journal:  Cerebellum       Date:  2016-06       Impact factor: 3.847

6.  Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats.

Authors:  Wacław Kolasiewicz; Katarzyna Kuter; Przemysław Nowak; Agnieszka Pastuszka; Krystyna Ossowska
Journal:  Cerebellum       Date:  2011-06       Impact factor: 3.847

7.  Hcn1 is a tremorgenic genetic component in a rat model of essential tremor.

Authors:  Yukihiro Ohno; Saki Shimizu; Ayaka Tatara; Takuji Imaoku; Takahiro Ishii; Masashi Sasa; Tadao Serikawa; Takashi Kuramoto
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

8.  Activation of immediate-early response gene c-Fos protein in the rat paralimbic cortices after myocardial infarction.

Authors:  Ji Yun Ahn; Hyun-Jin Tae; Jeong-Hwi Cho; In Hye Kim; Ji Hyeon Ahn; Joon Ha Park; Dong Won Kim; Jun Hwi Cho; Moo-Ho Won; Seongkweon Hong; Jae-Chul Lee; Jeong Yeol Seo
Journal:  Neural Regen Res       Date:  2015-08       Impact factor: 5.135

9.  Oculopalatal tremor explained by a model of inferior olivary hypertrophy and cerebellar plasticity.

Authors:  Aasef G Shaikh; Simon Hong; Ke Liao; Jing Tian; David Solomon; David S Zee; R John Leigh; Lance M Optican
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

Review 10.  Rodent models of tremor.

Authors:  Hideto Miwa
Journal:  Cerebellum       Date:  2007       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.